<DOC>
	<DOCNO>NCT00424593</DOCNO>
	<brief_summary>The primary purpose participation study help answer follow research question , provide treatment condition . Whether duloxetine daily help patient Chronic Low Back Pain . Patients pain reduce least 30 % week 7 give 120 mg dose duration study . After 13 week double blind period , patient randomize placebo switch duloxetine 60 mg 120 mg 41-week extension period .</brief_summary>
	<brief_title>Duloxetine Versus Placebo Chronic Low Back Pain</brief_title>
	<detailed_description />
	<mesh_term>Back Pain</mesh_term>
	<mesh_term>Low Back Pain</mesh_term>
	<mesh_term>Duloxetine Hydrochloride</mesh_term>
	<criteria>Male/Female outpatient 18 year age chronic low back pain Females child bear potential must test negative pregnancy test visit 1 . Have serious unstable disease heart blood vessel , liver , kidney , lung , bloodrelated illness Problems decrease blood flow arm legs ( peripheral vascular disease ) , medical condition Psychiatric condition , opinion investigator , would affect participation likely lead hospitalization course study Have acute liver injury ( hepatitis ) severe cirrhosis Have previous exposure duloxetine Have body mass index ( BMI ) 40 Have major depressive disorder Require daily narcotic Have suicidal risk Have presence factors/conditions , medical , judgment investigator may interfere performance study outcome measure</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2009</verification_date>
</DOC>